Cytosens
Cytosens is an Italian life science distributor and services provider, headquartered in Milano with offices in Napoli and Lisboa, that supplies flow cytometry, 3D bioprinting, molecular biology, pathology, and spatial biology technologies to academic, research, and clinical laboratory customers in Southern Europe.
- Company typePrivate
- Founded2019
- HeadquartersMilano, Lombardia, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Cytosens does
Cytosens is a privately held Italian life science distribution and services company headquartered in Milano, with a secondary office in Napoli and a regional office in Lisboa, Portugal. The firm operates across five specialized divisions — Cytometry, Cellular, Molecular, Pathology, and Spatial Biology — plus a custom Life Science Services arm offering oligonucleotide synthesis, Sanger and next-generation sequencing, proteomics/mass spectrometry, interactomics, cell line supply, cryopreservation, and animal facility services. Its commercial proposition is to act as a curated "Life Science Technology Hub," consolidating international life science technologies into a single procurement channel for academic researchers, universities, research bodies, and clinical laboratories in Southern Europe.
Its core technology positioning rests on distributing patented platforms rather than inventing them. Cytosens holds authorized distributor status in Italy for Sony Biotechnology flow cytometry instruments and reagents, and an exclusive distribution agreement with Hawk Biosystems for the QF-Pro platform, which combines Fluorescence Lifetime Imaging Microscopy (FLIM) and Förster Resonance Energy Transfer (FRET) to spatially quantify functional proteomic events in FFPE tissue. The accompanying Violet 3.0 all-in-one benchtop microscopy platform and proprietary QF-Pro reagent kits (covering up to 100 FFPE slides or a 96-well plate per kit, stable for at least six months) are bundled under the Spatial Biology division. Additional offerings include 3D bioprinting and organoid tools under the Cellular division.
The business model is a hybrid of authorized hardware and consumables distribution plus fee-for-service lab work. Revenue derives from resale of instruments and reagents (Sony Biotechnology, Hawk Biosystems, ThinkCyte, De Novo Software product lines), recurring consumables pull-through (notably QF-Pro reagent kits and cytometry reagents), and bespoke services such as Sanger sequencing at quoted turnaround SLAs (99% accuracy for the first 700 bp, 48-hour email results) and oligonucleotide delivery within 24–72 hours. Go-to-market is sales-led, executed through a direct sales network supported by application specialists and engineers, with marketing driven by the corporate website, division-specific subdomain portals, an email newsletter, and organic social presence on LinkedIn and Facebook. Pricing is quote-based and not publicly disclosed.
Cytosens firmographics
Firmographics- Name
- Cytosens
- Legal name
- Cytosens
- Website
- https://cytosens.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cytosens is an Italian life science distributor and services provider, headquartered in Milano with offices in Napoli and Lisboa, that supplies flow cytometry, 3D bioprinting, molecular biology, pathology, and spatial biology technologies to academic, research, and clinical laboratory customers in Southern Europe.
- Ownership category
- akta.pro rank
Cytosens industry classification
Industry- Product category
- Life Science Technology Distribution
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Cytosens is headquartered
LocationHeadquarters
- HQ city
- Milano, Lombardia
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Cytosens business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Life Science Products Distribution: Distribution of cutting-edge life science technologies including flow cytometry instruments and reagents, 3D cell culture and bioprinting tools, molecular biology reagents and instruments, pathology solutions, and spatial biology platforms across Italy and Portugal.
- Custom Life Science Services: Outsourced experimental solutions including oligonucleotide synthesis, Sanger and NGS sequencing, proteomics/mass spectrometry, interactomics, cell line supply, cryopreservation, and animal facility services for universities, research bodies, and public/private laboratories.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Cytosens product offering
Product offeringCore offering
Cytosens operates as a Life Science Technology Hub, distributing cutting-edge life science products and instruments across five specialized divisions (Cytometry, Cellular, Molecular, Pathology, and Spatial Biology) in Italy and Portugal. The company also provides custom life science services including oligonucleotide synthesis, Sanger sequencing, NGS, proteomics/mass spectrometry, interactomics, cell line supply, cryopreservation, and animal facility services for academic, research, and clinical customers. As authorized distributor of Sony Biotechnology products in Italy and exclusive distributor of Hawk Biosystems' QF-Pro technology, Cytosens combines hardware/reagent distribution with outsourced experimental services.
Product overview
Cytosens operates as a Life Science Technology Hub providing a comprehensive suite of products and services across five divisions: Cytometry (flow cytometry instruments, cell sorters, reagents), Cellular (3D cell culture and bioprinting tools), Molecular (reagents for gene expression and sequencing), Pathology (diagnostic solutions), and Spatial Biology (tissue cytometry and spatial omics). The Spatial Biology division features HAWK Biosystems' QF-Pro technology, including the Violet 3.0 all-in-one microscopy platform and QF-Pro Reagent Kits, which enable spatial quantification of protein functions using FLIM and FRET. Life Science Services include oligonucleotide synthesis, Sanger and NGS sequencing, proteomics, interactomics, cell line supply, cryopreservation, and animal facility services. The company operates as a distributor for Sony Biotechnology products in Italy.
Differentiator
Problem solved
Functional benefit
Brands
- Cytometry: Division dedicated to advanced flow cytometry, providing cutting-edge instruments and support for every aspect of analysis.
- Cellular
- Molecular
- Pathology
- Spatial Biology
Products and services
- Cytometry Division
- Cellular Division
- Molecular Division
- Pathology Division
- Spatial Biology Division
- Life Science Services
- QF-Pro Technology
- Violet 3.0 Microscopy Platform
- QF-Pro Reagent Kits
Quantifiable outcome
- 99% accuracy for first 700bp in Sanger sequencing services
- +2 more outcomes
Companies that use Cytosens
Customer profileSegments3 records
Ideal customer profiles3 records
Cytosens technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cytosens partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Sony BiotechnologycoreAuthorized distributor of Sony Biotechnology products including flow cytometers, cell sorters, and cytometry reagents in Italy. Established after 10 years of experience in the flow cytometry field.
- Hawk BiosystemscoreExclusive distribution partnership for Hawk Biosystems' QF-Pro technology including Violet 3.0 all-in-one microscopy platform and QF-Pro reagent kits. QF-Pro is a patented bio-imaging platform for spatial quantification of functional proteomic events.
- ThinkCyteminorPartnership with ThinkCyte for cytometry products and reagents, featured alongside Sony Biotechnology as part of the complete solution for FACS labs.
Scale indicators1 record
Expansion highlights4 records
Cytosens competitors and assessment
Company assessmentBroad incumbents
- Bio-Techne: Large global life science tools manufacturer and distributor with a substantial European commercial footprint — broader portfolio and deeper resources make it an incumbent benchmark rather than a niche competitor.
- Carl Roth: European laboratory consumables and reagents supplier with broad catalog across molecular and cell biology — competes at the product breadth level across Cytosens' Molecular and Cellular divisions.
- Merck Life Science (Sigma-Aldrich): Global life science reagents, instruments, and consumables distributor with comprehensive coverage of academic and clinical accounts — competes at the full-portfolio level across all five of Cytosens' divisions.
- Avantor (VWR): Global laboratory products distributor with extensive Italian/Portuguese operations and a full-spectrum catalog — sets the pricing and procurement benchmark against which Cytosens competes.
Direct peers
- Euroclone: Italian life science products distributor offering cell culture, molecular biology, and instrumentation consumables to academic and clinical labs — a directly comparable Italian VAR with overlapping customer base and product categories.
- DBA Italia: Italian distributor of molecular biology, cell biology, and genomics reagents and instruments — directly competes with Cytosens' Molecular and Cellular divisions for the same research accounts.
- Diatech Lab Line: Italian distributor focused on diagnostics, pathology, and laboratory products — directly competes with Cytosens' Pathology division and shares the same clinical lab customer base.
- Aurogene: Italian genomics and molecular biology reagent supplier with custom sequencing services — overlaps with Cytosens' Molecular division and Sanger/NGS service offering.
- S.I.A.L. Group: Italian laboratory equipment and reagents distributor serving research and clinical diagnostics markets across multiple product lines — closely comparable in size, geography, and VAR-led go-to-market.
Emerging players
- Hawk Biosystems: Original manufacturer of the patented QF-Pro FLIM/FRET platform and reagent kits that Cytosens exclusively distributes — comparable as both a technology peer and a principal supplier relationship.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Cytosens social profiles
Digital presenceCytosens financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cytosens leadership team
Management profileNumber of profiles
Cytosens funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cytosens M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cytosens
What does Cytosens do?
Cytosens operates as a Life Science Technology Hub, distributing cutting-edge life science products and instruments across five specialized divisions (Cytometry, Cellular, Molecular, Pathology, and Spatial Biology) in Italy and Portugal. The company also provides custom life science services including oligonucleotide synthesis, Sanger sequencing, NGS, proteomics/mass spectrometry, interactomics, cell line supply, cryopreservation, and animal facility services for academic, research, and clinical customers. As authorized distributor of Sony Biotechnology products in Italy and exclusive distributor of Hawk Biosystems' QF-Pro technology, Cytosens combines hardware/reagent distribution with outsourced experimental services.
Is Cytosens a public or private company?
Cytosens is a private company. It is classified as unknown and is currently operating.
When was Cytosens founded?
Cytosens was founded in 2019. It employs 1 to 10 people.
Where is Cytosens based?
Cytosens is headquartered in Milano, Lombardia, Italy, in the Europe region.
How does Cytosens make money?
Two revenue lines are on record. Life Science Products Distribution is the primary driver. The others are custom Life Science Services.
Who are Cytosens's main competitors?
Broad incumbents on record are Bio-Techne, Carl Roth, Merck Life Science (Sigma-Aldrich) and Avantor (VWR). Direct peers are Euroclone, DBA Italia, Diatech Lab Line, Aurogene and S.I.A.L. Group. Hawk Biosystems is listed as an emerging player.
Does Cytosens have an API?
No public API is recorded for Cytosens.
What industry is Cytosens in?
Cytosens's product category is Life Science Technology Distribution. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 541714 and its SIC code is 5122.